-
Je něco špatně v tomto záznamu ?
The characterization of four gene expression analysis in circulating tumor cells made by Multiplex-PCR from the AdnaTest kit on the lab-on-a-chip Agilent DNA 1000 platform
M. Škereňová, V. Mikulová, O. Čapoun, T. Zima,
Jazyk angličtina Země Chorvatsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT12205
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
PubMed Central
od 2012
Europe PubMed Central
od 2012 do 2020
Open Access Digital Library
od 2012-01-01
Medline Complete (EBSCOhost)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
PubMed
26981024
DOI
10.11613/bm.2016.011
Knihovny.cz E-zdroje
- MeSH
- aktiny genetika MeSH
- antigeny povrchové genetika MeSH
- DNA nádorová genetika MeSH
- erbB receptory genetika MeSH
- glutamátkarboxypeptidasa II genetika MeSH
- laboratoř na čipu * MeSH
- lidé MeSH
- multiplexová polymerázová řetězová reakce metody MeSH
- nádorové biomarkery genetika MeSH
- nádorové cirkulující buňky metabolismus MeSH
- nádory prostaty rezistentní na kastraci krev genetika MeSH
- prostatický specifický antigen genetika MeSH
- reagenční diagnostické soupravy MeSH
- regulace genové exprese u nádorů * MeSH
- reprodukovatelnost výsledků MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
INTRODUCTION: Nowadays, on-a-chip capillary electrophoresis is a routine method for the detection of PCR fragments. The Agilent 2100 Bioanalyzer was one of the first commercial devices in this field. Our project was designed to study the characteristics of Agilent DNA 1000 kit in PCR fragment analysis as a part of circulating tumour cell (CTC) detection technique. Despite the common use of this kit a complex analysis of the results from a long-term project is still missing. MATERIALS AND METHODS: A commercially available Agilent DNA 1000 kit was used as a final step in the CTC detection (AdnaTest) for the determination of the presence of PCR fragments generated by Multiplex PCR. Data from 30 prostate cancer patients obtained during two years of research were analyzed to determine the trueness and precision of the PCR fragment size determination. Additional experiments were performed to demonstrate the precision (repeatability, reproducibility) and robustness of PCR fragment concentration determination. RESULTS: The trueness and precision of the size determination was below 3% and 2% respectively. The repeatability of the concentration determination was below 15%. The difference in concentration determination increases when Multiplex-PCR/storage step is added between the two measurements of one sample. CONCLUSIONS: The characteristics established in our study are in concordance with the manufacturer's specifications established for a ladder as a sample. However, the concentration determination may vary depending on chip preparation, sample storage and concentration. The 15% variation of concentration determination repeatability was shown to be partly proportional and can be suppressed by proper normalization.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16019994
- 003
- CZ-PrNML
- 005
- 20181105101750.0
- 007
- ta
- 008
- 160722s2016 ci f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.11613/BM.2016.011 $2 doi
- 024 7_
- $a 10.11613/BM.2016.011 $2 doi
- 035 __
- $a (PubMed)26981024
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ci
- 100 1_
- $a Škereňová, Markéta $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Czech Republic. $7 xx0208973
- 245 14
- $a The characterization of four gene expression analysis in circulating tumor cells made by Multiplex-PCR from the AdnaTest kit on the lab-on-a-chip Agilent DNA 1000 platform / $c M. Škereňová, V. Mikulová, O. Čapoun, T. Zima,
- 520 9_
- $a INTRODUCTION: Nowadays, on-a-chip capillary electrophoresis is a routine method for the detection of PCR fragments. The Agilent 2100 Bioanalyzer was one of the first commercial devices in this field. Our project was designed to study the characteristics of Agilent DNA 1000 kit in PCR fragment analysis as a part of circulating tumour cell (CTC) detection technique. Despite the common use of this kit a complex analysis of the results from a long-term project is still missing. MATERIALS AND METHODS: A commercially available Agilent DNA 1000 kit was used as a final step in the CTC detection (AdnaTest) for the determination of the presence of PCR fragments generated by Multiplex PCR. Data from 30 prostate cancer patients obtained during two years of research were analyzed to determine the trueness and precision of the PCR fragment size determination. Additional experiments were performed to demonstrate the precision (repeatability, reproducibility) and robustness of PCR fragment concentration determination. RESULTS: The trueness and precision of the size determination was below 3% and 2% respectively. The repeatability of the concentration determination was below 15%. The difference in concentration determination increases when Multiplex-PCR/storage step is added between the two measurements of one sample. CONCLUSIONS: The characteristics established in our study are in concordance with the manufacturer's specifications established for a ladder as a sample. However, the concentration determination may vary depending on chip preparation, sample storage and concentration. The 15% variation of concentration determination repeatability was shown to be partly proportional and can be suppressed by proper normalization.
- 650 _2
- $a aktiny $x genetika $7 D000199
- 650 _2
- $a antigeny povrchové $x genetika $7 D000954
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 _2
- $a DNA nádorová $x genetika $7 D004273
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a glutamátkarboxypeptidasa II $x genetika $7 D043425
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a laboratoř na čipu $7 D056656
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a multiplexová polymerázová řetězová reakce $x metody $7 D060885
- 650 _2
- $a nádorové cirkulující buňky $x metabolismus $7 D009360
- 650 _2
- $a prostatický specifický antigen $x genetika $7 D017430
- 650 _2
- $a nádory prostaty rezistentní na kastraci $x krev $x genetika $7 D064129
- 650 _2
- $a reagenční diagnostické soupravy $7 D011933
- 650 _2
- $a erbB receptory $x genetika $7 D066246
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mikulová, Veronika $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Czech Republic. $7 xx0208972
- 700 1_
- $a Čapoun, Otakar $u Department of Urology, General University Hospital and First Faculty of Medicine, Charles University in Prague, Czech Republic.
- 700 1_
- $a Zima, Tomáš $u Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Czech Republic.
- 773 0_
- $w MED00165904 $t Biochemia medica $x 1330-0962 $g Roč. 26, č. 1 (2016), s. 103-113
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26981024 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20181105101824 $b ABA008
- 999 __
- $a ok $b bmc $g 1154664 $s 944522
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 26 $c 1 $d 103-113 $i 1330-0962 $m Biochemia medica $n Biochem. med. $x MED00165904
- GRA __
- $a NT12205 $p MZ0
- LZP __
- $a Pubmed-20160722